The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

IntroductionPrevious studies have demonstrated that programmed cell death-ligand 1 (PD-L1) serves as biomarker for poor prognosis and survival in advanced-stage non-small cell lung cancer (NSCLC) patients. However, the merit of PD-L1 expression to predict the prognosis of early stage NSCLC patients...

Full description

Bibliographic Details
Main Authors: Tao Shi, Shuai Zhu, Hengjuan Guo, Xiongfei Li, Shikang Zhao, Yanye Wang, Xi Lei, Dingzhi Huang, Ling Peng, Ziming Li, Song Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
PD-L1
NSCLC
meta-analysis
prognosis
resection
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.567978/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.567978/full

Similar Items